Utah Medical Products reports Q3 2022 earnings; no specific figures available in excerpt

UTAH MEDICAL PRODUCTS INC

2022-Q3 EPS reported $3.26 revenue$38,707,000

Financial information for three and nine months ended September 30, 2022 is included.
Forward-looking statements relating to 2022 and beyond are provided.
No specific revenue or EPS figures are available in this summary due to missing exhibit data.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.